top of page

Biosimilars, toripalimab, and TIGIT with the CEO of Coherus.

Coherus Biosciences CEO Denny Lanfear talks about trying to lower the cost of medicines through biosimilars and discusses his oncology programs.



Kommentare


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page